We are live on ! Find out more
KURA icon

Kura Oncology

171 hedge funds and large institutions have $1.94B invested in Kura Oncology in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 70 increasing their positions, 55 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,713% more call options, than puts

Call options by funds: $17M | Put options by funds: $446K

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

27% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 55

3.23% more ownership

Funds ownership: 100.36%103.59% (+3.2%)

9% less capital invested

Capital invested by funds: $2.12B → $1.94B (-$183M)

14% less funds holding

Funds holding: 198171 (-27)

68% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 37

Holders
171
Holders Change
-27
Holders Change %
-13.64%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
12
Increased
70
Reduced
55
Closed
37
Calls
$17M
Puts
$446K
Net Calls
+$16.6M
Net Calls Change
-$394K
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
$4.04M +$4.06M +128,371 +874%
Barclays
52
Barclays
United Kingdom
$3.85M +$3.63M +114,698 +533%
Swiss National Bank
53
Swiss National Bank
Switzerland
$3.56M +$69.6K +2,200 +2%
PVI
54
Pura Vida Investments
New York
$3.51M +$1.53M +48,440 +64%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$3.48M -$658K -20,784 -14%
AllianceBernstein
56
AllianceBernstein
Tennessee
$3.39M +$1.3M +41,218 +52%
Assenagon Asset Management
57
Assenagon Asset Management
Luxembourg
$3.34M
Rafferty Asset Management
58
Rafferty Asset Management
New York
$3.19M +$2.86M +90,544 +404%
Wells Fargo
59
Wells Fargo
California
$3M -$2.05M -64,779 -38%
CLOS
60
Compagnie Lombard Odier SCmA
Switzerland
$2.95M +$3.3M +104,293 New
LOAMS
61
Lombard Odier Asset Management (Switzerland)
Switzerland
$2.95M +$3.3M +104,293 New
SG Americas Securities
62
SG Americas Securities
New York
$2.79M +$309K +9,751 +11%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$2.67M +$43.5K +1,374 +1%
SSA
64
Schonfeld Strategic Advisors
New York
$2.4M +$2.04M +64,464 +319%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$2.38M -$38K -1,200 -1%
SI
66
Sofinnova Investments
California
$2.35M -$1.19M -37,513 -31%
Bank of America
67
Bank of America
North Carolina
$2.33M +$204K +6,434 +8%
B
68
Bailard
California
$2.32M +$1.33M +42,000 +105%
SCM
69
Silverarc Capital Management
Massachusetts
$2.26M -$316K -10,000 -11%
CAM
70
Connacht Asset Management
New York
$2.19M +$2.45M +77,501 New
AGA
71
Altrinsic Global Advisors
Connecticut
$1.98M -$158K -5,000 -7%
State of New Jersey Common Pension Fund D
72
State of New Jersey Common Pension Fund D
New Jersey
$1.97M +$167K +5,276 +8%
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
$1.91M -$79K -2,498 -4%
DekaBank Deutsche Girozentrale
74
DekaBank Deutsche Girozentrale
Germany
$1.78M
IHAM
75
Integral Health Asset Management
New York
$1.7M -$1.11M -35,000 -37%

KURA Hedge Fund Activity: Q1 2021 in Review

171 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2021, worth a combined $1.94B — down 8.6% from $2.12B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of KURA and 12 opened new positions — a net loss of 25 holders — while 55 trimmed existing stakes and 70 added.

The largest buyer was EcoR1 Capital, adding an estimated $60.7M. The largest seller was Citadel Advisors, cutting an estimated $51.6M.

  • 171 institutional investors held Kura Oncology (KURA) as of Q1 2021, down from 198 in Q4 2020.
  • Funds reported $1.94B of Kura Oncology stock for Q1 2021, down 8.6% quarter-over-quarter.
  • 12 funds opened new Kura Oncology positions in Q1 2021 and 37 closed out, a net change of -25 holders.
  • The largest Kura Oncology buyer in Q1 2021 was EcoR1 Capital, an estimated $60.7M added.
  • The largest Kura Oncology seller in Q1 2021 was Citadel Advisors, an estimated $51.6M sold.

Based on aggregated 13F filings for Q1 2021.